|
Index of reports
> Death (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Apresoline (Hydralazine) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Apresoline side effects in 35 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2011-11-21
Patient: 35 year old female, weighing 65.0 kg (143.0 pounds)
Reactions: Phaeochromocytoma, NO Therapeutic Response, Tachycardia, Circulatory Collapse, Ventricular Fibrillation, Loss of Consciousness
Adverse event resulted in: death
Drug(s) suspected as cause:
Labetalol Hydrochloride
Dosage: 35 mg; iv
Indication: Hypertension
Nicardipine HCL
Dosage: 2 mg; iv
Indication: Hypertension
Apresoline
Dosage: 10 mg; iv
Indication: Hypertension
Other drugs received by patient: Acebutolol; Methyldopa
Possible Apresoline side effects in 35 year old female
Reported by a individual with unspecified qualification from Japan on 2011-10-06
Patient: 35 year old female, weighing 64.0 kg (140.8 pounds)
Reactions: Phaeochromocytoma, Drug Ineffective, Maternal Exposure During Pregnancy, Tachycardia, Loss of Consciousness, Hypertensive Crisis, Circulatory Collapse, Ventricular Fibrillation
Adverse event resulted in: death
Drug(s) suspected as cause:
Labetalol HCL
Dosage: 35 mg, unk
Indication: Hypertensive Crisis
Apresoline
Dosage: 10 mg, unk
Apresoline
Dosage: 5 mg, unk
Nicardipine HCL
Dosage: 1 mg, unk
Indication: Hypertension
Nicardipine HCL
Dosage: 2 mg, unk
Other drugs received by patient: Dopamine HCL
|
